![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Moscatiello Simona Di Luzio Raffaella Sasdelli Anna Simona Marchesini Giulio
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.12, Iss.17, 2011-12, pp. : 2657-2672
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome
Current Pharmaceutical Design, Vol. 13, Iss. 21, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Al-Gayyar Mohammed M. H. Shams Mohamed E. E. Barakat Enaase A. M. E.
Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 50, Iss. 3, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Nonalcoholic fatty liver disease: a review
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-04 ,pp. :